RETRACTED: Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents (Retracted article. See vol. 423, pg. 154, 2018)

被引:25
作者
Ali, Shadan [2 ]
Varghese, Lalee [1 ]
Pereira, Lucio [3 ]
Tulunay-Ugur, Ozlem E. [3 ]
Kucuk, Omer [2 ]
Carey, Thomas E. [4 ]
Wolf, Gregory T. [4 ]
Sarkar, Fazlul H. [1 ]
机构
[1] Wayne State Univ, Dept Pathol, Karmanos Canc Ctr, Detroit, MI 48202 USA
[2] Wayne State Univ, Div Hematol Oncol, Karmanos Canc Ctr, Detroit, MI USA
[3] Wayne State Univ, Dept Otolaryngol, Karmanos Canc Ctr, Detroit, MI 48201 USA
[4] Univ Michigan, Dept Otolaryngol, Ann Arbor, MI 48109 USA
关键词
Uterine cervix cancer; 3,3 '-Dindolylmethane; G2535; Cisplatin resistance; NF-kappa B; FACTOR-KAPPA-B; SOY ISOFLAVONE GENISTEIN; ENDOPLASMIC-RETICULUM STRESS; BREAST-CANCER CELLS; PANCREATIC-CANCER; NECK-CANCER; 3,3'-DIINDOLYLMETHANE DIM; CHEMOTHERAPEUTIC-AGENTS; CERVICAL-CANCER; ADVANCED HEAD;
D O I
10.1016/j.canlet.2009.01.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cisplatin resistance is a major problem in the successful treatment of squamous cell carcinoma (SCC). In the present study we showed, for the first time, that the constitutive activation of NF-kappa B partly contributes to cisplatin resistance and that the inactivation of NF-kappa B by natural agents [G2535 (isoflavone mixture containing genistein and diadzein), 3,3'-diindolylmethane (Bioresponse BR-DIM referred to as B-DIM)] could overcome this resistance, resulting in the inhibition of cell growth and induction of apoptosis, which might be an useful strategy for achieving better treatment outcome in patients diagnosed with cisplatin-resistant tumors of SCC. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:201 / 209
页数:9
相关论文
共 40 条
[1]   3,3′-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5 [J].
Abdelrahim, M ;
Newman, K ;
Vanderlaag, K ;
Samudio, I ;
Safe, S .
CARCINOGENESIS, 2006, 27 (04) :717-728
[2]   CHEMOTHERAPY STRATEGIES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
ALSARRAF, M .
CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1984, 1 (04) :323-355
[3]  
BANERJEE S, 2007, PANCREAS
[4]   Targeting apoptosis to overcome cisplatin resistance: A translational study in head and neck cancer [J].
Bauer, Joshua A. ;
Kumar, Bhavna ;
Cordell, Kitrina G. ;
Prince, Mark E. ;
Tran, Huong H. ;
Wolf, Gregory T. ;
Chepeha, Douglas B. ;
Teknos, Theodoros N. ;
Wang, Steven ;
Eisbruch, Avraham ;
Tsien, Christina I. ;
Urba, Susan G. ;
Worden, Francis P. ;
Lee, Julia ;
Griffith, Kent A. ;
Taylor, Jeremy M. G. ;
D'Silva, Nisha ;
Wang, Shaomeng J. ;
Wolter, Keith G. ;
Henson, Bradley ;
Fisher, Susan G. ;
Carey, Thomas E. ;
Bradford, Carol R. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (02) :S106-S108
[5]   Docetaxel in the management of patients with head and neck squamous cell carcinoma [J].
Bernier, Jacques ;
Vrieling, Conny .
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (07) :1023-1032
[6]   Natural history and epidemiology of HPV infection and cervical cancer [J].
Castellsague, Xavier .
GYNECOLOGIC ONCOLOGY, 2008, 110 (03) :S4-S7
[7]  
Chen Jake Y, 2007, J Bioinform Comput Biol, V5, P383, DOI 10.1142/S0219720007002606
[8]   RETRACTED: Potentiation of the effect of erlotinib by genistein in pancreatic cancer:: The role of Akt and nuclear factor-κB (Retracted article. See vol. 78, pg. 5472, 2018) [J].
El-Rayes, Basil F. ;
Ali, Shadan ;
Ali, Ifrah F. ;
Philip, Philip A. ;
Abbruzzese, James ;
Sarkar, Fazlul H. .
CANCER RESEARCH, 2006, 66 (21) :10553-10559
[9]  
El-Rayes BF, 2004, MOL CANCER THER, V3, P1421
[10]   Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib [J].
Fahy, BN ;
Schlieman, MG ;
Mortenson, MM ;
Virudachalam, S ;
Bold, RJ .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (01) :46-54